The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients.

Autor:	Onoe, Hiromitsu1 (AUTHOR) onoehir@hiroshima-u.ac.jp, Hirooka, Kazuyuki1 (AUTHOR) khirooka9@gmail.com, Baba, Tetsuya2 (AUTHOR) tbaba@shirai-hosp.or.jp, Nagayama, Mikio3 (AUTHOR) mikio@po.harenet.ne.jp, Hirota, Atsushi4 (AUTHOR) hirotaganka@lion.ocn.ne.jp, Suzuki, Katsuyoshi5 (AUTHOR) suzuki_eye@grace.ocn.ne.jp, Sagara, Takeshi6 (AUTHOR) tsagara65@gmail.com, Mochizuki, Hideki7 (AUTHOR) mochizuki-h@hiroshima-u.ac.jp, Kiuchi, Yoshiaki1 (AUTHOR)
Zdroj:	Journal of Clinical Medicine. Jul2024, Vol. 13 Issue 14, p4158. 8p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu